Omslagsbillede

Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30

Guardado en:
Udgivet i:Health Affairs vol. 39, no. 8 (Aug 2020), p. 1343
Hovedforfatter: Sim, So Yoon
Andre forfattere: Watts, Elizabeth, Constenla, Dagna, Brenzel, Logan, Patenaude, Bryan N
Udgivet:
The People to People Health Foundation, Inc., Project HOPE
Fag:
United Nations Childrens Fund > UNICEF World Health Organization United Nations > UN
United States > US
Infectious diseases
Pathogens
Vaccines
Investments
Rubella
Immunization
Return on investment
Productivity
Cost estimates
Prices
Health facilities
Human papillomavirus
Costs
Encephalitis
Income
Low income groups
Illnesses
Decision making
Measles
Viruses
Gross Domestic Product > GDP
Streptococcus infections
Informal economy
Value
Rotavirus
Willingness to pay
Policy making
Health initiatives
Resource allocation
Health care expenditures
Decision makers
Global health
Benefits
Economic
Online adgang:Citation/Abstract
Full Text
Full Text - PDF
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
Resumen:Estimating the value of global investment in immunization programs is critical to helping decision makers plan and mobilize immunization programs and allocate resources required to realize their full benefits. We estimated economic benefits using cost-of-illness and value-of-a-statistical-life approaches and combined this estimation with immunization program costs to derive the return on investment from immunization programs against ten pathogens for ninety-four low- and middle-income countries for the period 2011-30. Using the cost-of-illness approach, return on investment for one dollar invested in immunization against our ten pathogens was 26.1 for the ninety-four countries from 2011 to 2020 and 19.8 from 2021 to 2030. Using the value-of-a-statisticallife approach, return on investment was 51.0 from 2011 to 2020 and 52.2 from 2021 to 2030. The results demonstrate continued high return on investment from immunization programs. The return-on-investment estimates from this study will inform country policy makers and decision makers in funding agencies and will contribute to efforts to mobilize resources for immunization. Realization of the full benefits of immunization will depend on sustained investment in and commitment to immunization programs.
ISSN:0278-2715
1544-5208
DOI:10.1377/hlthaff.2020.00103
Fuente:ABI/INFORM Global